Calls for papers
-
Aptar Pharma has announced the selection of a customized Landmark dose indicator for Skyepharma’s Flutiform fluticasone propionate/formoterol fumarate MDI. Flutiform is available for the treatment of asthma in Germany, the UK, and several other countries.… Read more . . .
-
The US Patent and Trademark Office has issued Patent number 8,324,266, titled “Compositions, Methods & Systems for Respiratory Delivery of Two or More Active Agents,” to Pearl Therapeutics. The patent covers formulation methods using the… Read more . . .
-
Prosonix has announced that Ken Cunningham will replace Jim Philips as Non-executive Chairman. Cunningham, who is also Chair of the company’s scientific advisory board, is a former CEO of Skyepharma. He has been a member… Read more . . .
-
According to Consort Medical, Nicoventures, a subsidiary of the British American Tobacco Group, has awarded a contract to Consort’s Bespak Division “for the supply of an innovative nicotine inhalation product for use as a safer… Read more . . .
-
Lightlake Therapeutics, which is developing intranasal naloxone to treat eating disorders, has announced the appointment of board member Kevin Pollack as Chief Financial Officer. Pollack joined the board of directors in April 2012. Lightlake Chief… Read more . . .
-
Inhalation and particle engineering specialist Hovione and Swiss chemical development company Solvias have announced an agreement to collaborate on development and manufacturing of co-crystallized drugs. According to Hovione, “This strengthens Hovione’s expertise and experience in… Read more . . .
-
The FDA issued a letter to Alcon dated November 13, 2012 regarding a sales aid that the agency says overstates the efficacy of Alcon’s Patanase olopatadine hydrochloride nasal spray. In the four-page letter, the agency… Read more . . .
-
Maryland-based CRO Next Breath, which specializes in OINDP analysis, has announced that an October 15, 2012 GMP inspection by the FDA found the company’s Baltimore facility to be compliant. The inspection resulted in no Form… Read more . . .
-
OINDP component manufacturer Presspart has announced the appointment of Ameet Sule as Director of its new Inhalation Product Technology Centre (IPTC) in Blackburn, UK. Sule, who was most recently Director of Pulmonary Research at Lupin,… Read more . . .
-
Fortical salmon calcitonin nasal spray manufacturer Unigene says that it is in danger of running out of cash before the end of the first quarter of 2013, due in part to the EMA’s July 2012… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK